Abstract: The present disclosure relates to oral dosage forms of pharmaceutical formulations that comprise an antiviral nucleoside, one or more compression aids, one or more glidants, and one or more lubricants, and one or more disintegrants, wherein the oral dosage form is a pellet having a diameter of less than or equal to 4.0 mm.

Abstract: A method for performing email analytics is described. The method includes extracting emails from the configured email repository. The emails are then grouped into mail groups based on identification of content similarity of the emails. A network graph is then constructed for each of the mail group to identify an association of emails in the mail group based on header-level analysis of emails. Thereafter, email analytics is performed on the mail groups by clustering the mail groups into mail clusters based on temporal progression of emails in the mail groups. Key phrases are then determined based on a content analysis of emails in the mail groups in the mail clusters. The key phrases are then associated with the network graphs of the mail groups.

Abstract: A method for performing email analytics is described. The method includes extracting emails from the configured email repository. The emails are then grouped into mail groups based on identification of content similarity of the emails. A network graph is then constructed for each of the mail group to identify an association of emails in the mail group based on header-level analysis of emails. Thereafter, email analytics is performed on the mail groups by clustering the mail groups into mail clusters based on temporal progression of emails in the mail groups. Key phrases are then determined based on a content analysis of emails in the mail groups in the mail clusters. The key phrases are then associated with the network graphs of the mail groups.